Clearly, insulin therapy causes chronic peripheral hyperinsulinemia, and several studies have attempted to clarify whether long-term treatment with insulin or insulin analogs may increase the risk of overall cancer mortality and incidence in patients with T2DM (240, 241). The gene discussed is INS; the disease is type 2 diabetes mellitus.